NLS Pharmaceutics Ltd. /
Kadimastem Ltd.
NLS Pharmaceutics and Kadimastem extend merger agreement timeline
Source for the buyer and target: NLS Pharmaceutics Ltd.
For the buyer and target.
“Seventh Amendment to the Agreement and Plan of Merger, dated August 29, 2025, among NLS Pharmaceutics Ltd., NLS Pharmaceutics (Israel Ltd.), and Kadimastem Ltd.”
Published 29 Aug 2025
Open the sourceWhat happened
NLS Pharmaceutics Ltd. and Kadimastem Ltd. agreed to extend the merger agreement’s termination date from August 31, 2025 to October 31, 2025. The extension provides additional time to complete the merger. [01]
The source
Everything on this page comes from the source below, quoted word for word.
NLS Pharmaceutics and Kadimastem extend merger agreement timeline
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Also stated
“NLS Pharmaceutics and Kadimastem extend merger agreement timeline NLS Pharmaceutics Ltd. and Kadimastem Ltd. agreed to extend the merger agreement’s termination date from August 31, 2025 to October 31, 2025”
Open the sourceAlso stated
“NLS Pharmaceutics and Kadimastem extend merger agreement timeline NLS Pharmaceutics Ltd. and Kadimastem Ltd. agreed to extend the merger agreement’s termination date from August 31, 2025 to October 31, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly